Annual EBITDA
-$57.04 M
-$1.05 M-1.87%
December 31, 2023
Summary
- As of February 7, 2025, LUNG annual EBITDA is -$57.04 million, with the most recent change of -$1.05 million (-1.87%) on December 31, 2023.
- During the last 3 years, LUNG annual EBITDA has fallen by -$28.69 million (-101.17%).
- LUNG annual EBITDA is now -263.85% below its all-time high of -$15.68 million, reached on December 31, 2018.
Performance
LUNG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$12.69 M
+$1.27 M+9.07%
September 30, 2024
Summary
- As of February 7, 2025, LUNG quarterly EBITDA is -$12.69 million, with the most recent change of +$1.27 million (+9.07%) on September 30, 2024.
- Over the past year, LUNG quarterly EBITDA has dropped by -$237.00 thousand (-1.90%).
- LUNG quarterly EBITDA is now -390.53% below its all-time high of -$2.59 million, reached on September 30, 2020.
Performance
LUNG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$51.34 M
+$848.00 K+1.62%
September 30, 2024
Summary
- As of February 7, 2025, LUNG TTM EBITDA is -$51.34 million, with the most recent change of +$848.00 thousand (+1.62%) on September 30, 2024.
- Over the past year, LUNG TTM EBITDA has increased by +$4.15 million (+7.48%).
- LUNG TTM EBITDA is now -1290.98% below its all-time high of -$3.69 million, reached on September 30, 2019.
Performance
LUNG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LUNG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.9% | -1.9% | +7.5% |
| 3 y3 years | -101.2% | -1.9% | +7.5% |
| 5 y5 years | -263.9% | -1.9% | +7.5% |
LUNG EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.4% | at low | -3.5% | +16.5% | -10.1% | +8.9% |
| 5 y | 5-year | -223.0% | at low | -390.5% | +16.5% | -571.0% | +8.9% |
| alltime | all time | -263.9% | at low | -390.5% | +16.5% | -1291.0% | +8.9% |
Pulmonx EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.69 M(-9.1%) | -$51.34 M(-1.6%) |
| Jun 2024 | - | -$13.95 M(+13.8%) | -$52.19 M(-1.6%) |
| Mar 2024 | - | -$12.26 M(-1.5%) | -$53.02 M(-4.5%) |
| Dec 2023 | -$57.04 M(+1.9%) | -$12.45 M(-8.0%) | -$55.49 M(-1.5%) |
| Sep 2023 | - | -$13.53 M(-8.4%) | -$56.34 M(+0.1%) |
| Jun 2023 | - | -$14.78 M(+0.4%) | -$56.30 M(+1.4%) |
| Mar 2023 | - | -$14.73 M(+10.8%) | -$55.52 M(-0.8%) |
| Dec 2022 | -$55.99 M(+20.1%) | -$13.29 M(-1.6%) | -$55.99 M(+1.8%) |
| Sep 2022 | - | -$13.50 M(-3.6%) | -$54.98 M(+7.4%) |
| Jun 2022 | - | -$14.00 M(-7.9%) | -$51.20 M(+3.0%) |
| Mar 2022 | - | -$15.20 M(+23.7%) | -$49.73 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$46.62 M(+64.4%) | -$12.28 M(+26.3%) | -$46.62 M(+7.9%) |
| Sep 2021 | - | -$9.72 M(-22.4%) | -$43.22 M(+19.8%) |
| Jun 2021 | - | -$12.53 M(+3.7%) | -$36.08 M(+5.0%) |
| Mar 2021 | - | -$12.09 M(+36.1%) | -$34.38 M(+21.3%) |
| Dec 2020 | -$28.35 M(+60.6%) | -$8.88 M(+243.4%) | -$28.35 M(+21.0%) |
| Sep 2020 | - | -$2.59 M(-76.1%) | -$23.43 M(-4.5%) |
| Jun 2020 | - | -$10.83 M(+78.6%) | -$24.54 M(+79.0%) |
| Mar 2020 | - | -$6.06 M(+53.1%) | -$13.71 M(+79.2%) |
| Dec 2019 | -$17.66 M(+12.6%) | -$3.96 M(+7.3%) | -$7.65 M(+107.3%) |
| Sep 2019 | - | -$3.69 M | -$3.69 M |
| Dec 2018 | -$15.68 M | - | - |
FAQ
- What is Pulmonx annual EBITDA?
- What is the all time high annual EBITDA for Pulmonx?
- What is Pulmonx annual EBITDA year-on-year change?
- What is Pulmonx quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pulmonx?
- What is Pulmonx quarterly EBITDA year-on-year change?
- What is Pulmonx TTM EBITDA?
- What is the all time high TTM EBITDA for Pulmonx?
- What is Pulmonx TTM EBITDA year-on-year change?
What is Pulmonx annual EBITDA?
The current annual EBITDA of LUNG is -$57.04 M
What is the all time high annual EBITDA for Pulmonx?
Pulmonx all-time high annual EBITDA is -$15.68 M
What is Pulmonx annual EBITDA year-on-year change?
Over the past year, LUNG annual EBITDA has changed by -$1.05 M (-1.87%)
What is Pulmonx quarterly EBITDA?
The current quarterly EBITDA of LUNG is -$12.69 M
What is the all time high quarterly EBITDA for Pulmonx?
Pulmonx all-time high quarterly EBITDA is -$2.59 M
What is Pulmonx quarterly EBITDA year-on-year change?
Over the past year, LUNG quarterly EBITDA has changed by -$237.00 K (-1.90%)
What is Pulmonx TTM EBITDA?
The current TTM EBITDA of LUNG is -$51.34 M
What is the all time high TTM EBITDA for Pulmonx?
Pulmonx all-time high TTM EBITDA is -$3.69 M
What is Pulmonx TTM EBITDA year-on-year change?
Over the past year, LUNG TTM EBITDA has changed by +$4.15 M (+7.48%)